BioScrip (BIOS) Misses Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
BioScrip Reports Second Quarter 2016 Financial Results
August 8, 2016 6:50 AM EDTQ2 Consolidated Revenue of $232.5 Million, Loss from continuing operations, net of income taxes of $(8.3) Million and Adjusted EBITDA of $10.4 Million
Full Year 2016 Guidance Updated to Reflect Pending Acquisition of Home Solutions
DENVER, Aug. 08, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) (BioScrip or the Company) today announced financial results for the second quarter 2016. For the second quarter, the Company reported revenue from continuing operations of $232.5 million, net loss from continuing operations of ($8.3) million and diluted EPS of ($0.14) loss per share.                               ... More
